Public | |
Traded as | |
Industry | Pharmaceuticals |
Founded | 1876 |
Founder | Eli Lilly |
Headquarters | Indianapolis, Indiana, United States |
Key people
|
Dave Ricks (Chairman of the Board)(President and CEO) |
Products | Drugs |
Revenue | US$21.221 billion (2016) |
US$2.79 billion (2016) | |
US$2.73 billion (2016) | |
Total assets | US$38.8 billion (2016) |
Total equity | US$14.08 billion (2016) |
Number of employees
|
41,975 (2016) |
Website | Lilly.com |
Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named. Eli Lilly and Company is listed on the and its shares have been a component of the S&P 500 Index since 1971.
Lilly was the first company to mass-produce penicillin, the Salk polio vaccine, and insulin. Its achievements include being one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin, Humalog, and the first approved biosimilar insulin product in the US, Basaglar. Lilly is also the world's largest manufacturer and distributor of psychiatric medications including Prozac (Fluoxetine), Dolophine (Methadone), Cymbalta (duloxetine), and Zyprexa (olanzapine).
A Fortune 500 corporation, Eli Lilly had revenues of $20 billion in 2008, making it the 148th largest company in the United States and the 10th largest corporation by global pharmaceutical sales. The company is publicly traded on the and is a member of the S&P 500 stock index. Eli Lilly was one of the Nifty Fifty stocks that propelled the mid-twentieth-century bull market.